FIELD: chemistry.
SUBSTANCE: invention relates to new salts 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazole-3-yl]oxy}methyl)piperidin-1-yl]methyl}tetrahydro2H-pyran-4-carboxylic acid, as well as to methods for producing such salt forms, pharmaceutical compositions containing them, their use for treating disease states mediated by 5-HT4 receptor activity.
EFFECT: technical result: new salt forms (HCl-salt, HBr-salt, p-toluenesulfonate salt and ethanedisulfonate salt) are obtained, possessing better stability and low hygroscopicity.
20 cl, 10 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
POLYMORPHIC FORMS | 2013 |
|
RU2659036C2 |
POLYMORPH FORM OF 4-{[4-({[4-(2,2,2-TRIFLUOROETHOXY)-1,2-BENZISOXAZOL-3-YL]OXY}METHYL)PIPERIDIN-1-YL]METHYL}-TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID | 2012 |
|
RU2616978C2 |
5-HT4 RECEPTOR AGONIST AS PROKINETIC AGENT | 2012 |
|
RU2597766C2 |
5-HT4-RECEPTOR AGONIST FOR GASTROPARESIS | 2015 |
|
RU2708686C2 |
N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
INDASOLES, BENZISOXAZOLES AND BENZISOTIAZOLES, METHOD OF THEIR OBTAINING, PHARMACEUTICAL COMPOSITIONS AND APPLICATION AS ESTROGENIC MEDICATIONS | 2005 |
|
RU2402536C2 |
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
PYRAZOLE QUINOLINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION | 2012 |
|
RU2621037C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
Authors
Dates
2019-02-12—Published
2015-05-20—Filed